[Management of hypertension in pregnancy and lactation]

Hypertensive disorders in pregnancy are common and carry significant maternal and fetal risks. Robust evidence from the CHAP- and CHIP-studies support clear management strategies including validated home or office blood pressure measurements, organ function assessment and sFlt-1/PIGF quotient for preeclampsia risk stratification. Treatment thresholds balance maternal protection and fetal growth, with methyldopa, nifedipine and metoprolol as primary options. Postpartum follow-up is essential, as affected women have lifelong elevated cardiovascular risk.